All News #Library
Biotech
Apertura, Viralgen Partner on TfR1 CapX for CNS Gene Therapies
17 Mar 2026 //
PR NEWSWIRE
Apertura Gene Therapy Launches Open Aperture
12 Feb 2026 //
PR NEWSWIRE
Apertura Licenses AAV Capsid for CNS Treatments
13 Aug 2025 //
PR NEWSWIRE
Apertura Gene Therapy Unveils Novel Engineered AAV Capsids
04 Jan 2024 //
BUSINESSWIRE
Apertura Gene Therapy Announces Scientific Founder Presentations on AAV Capsid
03 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support